These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26872011)

  • 21. More Than Meets the Eye? A Cautionary Tale of Malignant Ectomesenchymoma Treated as Low-risk Orbital Rhabdomyosarcoma.
    Rashid T; Bagatell R; Pawel B; Bentley RC; Kreissman SG; Deel MD
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e854-e858. PubMed ID: 32769567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS).
    Dantonello TM; Leuschner I; Vokuhl C; Gfroerer S; Schuck A; Kube S; Nathrath M; Bernbeck B; Kaatsch P; Pal N; Ljungman G; Bielack SS; Klingebiel T; Koscielniak E;
    Pediatr Blood Cancer; 2013 Feb; 60(2):224-9. PubMed ID: 22535600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
    Odeniyide P; Yohe ME; Pollard K; Vaseva AV; Calizo A; Zhang L; Rodriguez FJ; Gross JM; Allen AN; Wan X; Somwar R; Schreck KC; Kessler L; Wang J; Pratilas CA
    Oncogene; 2022 May; 41(21):2973-2983. PubMed ID: 35459782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma.
    Martinelli S; McDowell HP; Vigne SD; Kokai G; Uccini S; Tartaglia M; Dominici C
    Genes Chromosomes Cancer; 2009 Nov; 48(11):975-82. PubMed ID: 19681119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining an embryonal rhabdomyosarcoma endotype.
    Ricker CA; Crawford K; Matlock K; Lathara M; Seguin B; Rudzinski ER; Berlow NE; Keller C
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
    Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
    J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review.
    Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S
    Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
    Langenau DM; Keefe MD; Storer NY; Guyon JR; Kutok JL; Le X; Goessling W; Neuberg DS; Kunkel LM; Zon LI
    Genes Dev; 2007 Jun; 21(11):1382-95. PubMed ID: 17510286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
    Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
    J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.
    Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR
    Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ragab N; Bauer J; Botermann DS; Uhmann A; Hahn H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
    de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pelvic malignant ectomesenchymoma: a case report].
    Paramelle O; Croué A; Dupré F; Rialland X; Saint-André JP
    Ann Pathol; 2001 Aug; 21(4):344-7. PubMed ID: 11685134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.